Navigation Links
International symposium explores genetic link to mesothelioma and other cancers

HONOLULU--The University of Hawaii Cancer Center and The Queen's Medical Center (QMC) will host an international symposium on Friday, December 2, 2011 from 8:15 a.m. 4:30 p.m. at The Queen's Conference Center Auditorium to discuss new information related to the recent discovery of the BAP1 genetic mutation and its link to mesothelioma, melanoma and potentially other cancers.

The Third Annual Translational Cancer Medicine Symposium will feature more than 20 global experts in cancer genetics including keynote speaker, Carlo M. Croce, M.D., Director of the Human Cancer Genetics Program of The Ohio State University; Joseph Testa, Ph.D., Director of the Genomics Facility at Fox Chase Cancer Center; and Michele Carbone, M.D., Ph.D., Director of the University of Hawaii Cancer Center whose research team announced in August its discovery of the BAP1 gene mutation's link to mesothelioma and other cancers. "We are excited to bring these experts to Hawaii to work together to find ways to reduce the suffering and death from cancers caused by this mutation," said Carbone.

The BAP1 cancer syndrome is caused by inherited mutations of the BAP1 gene. Carriers of the BAP1 mutation can develop mesothelioma, uveal melanoma, melanocytic tumors and other carcinomas. When individuals with the BAP1 mutation are exposed to asbestos or erionite, mesothelioma appears to predominate and may be the cause of death in 50% of family members. This discovery provides physicians with a new tool to identify individuals at very high risk of developing these types of cancers. The study on the BAP1 discovery was published online in Nature Genetics on August 28, 2011.

Mesothelioma tumors are typically associated with asbestos and erionite exposure. Erionite, a naturally occurring mineral fiber similar to asbestos, is found in rock formations and volcanic ash. A small fraction of individuals exposed to erionite or asbestos actually develop mesothelioma, one of the deadliest forms of cancer that kills about 3,000 people each year in the United States, with half of those diagnosed dying within one year. Rates of new cases of mesothelioma in parts of the world, including Europe and China, have risen steadily over the past decade.

Funding for this event is provided by the Weinman Foundation's Innovators in Cancer Research Fund. This Fund was established in 2008 for the University of Hawaii Cancer Center by Barry and Virginia Weinman to promote translational cancer research aimed at moving cancer research findings to the patient's bedside. The Fund brings prominent leaders in cancer research to Hawaii each year to establish research collaborations with the University of Hawaii Cancer Center and members of the University of Hawaii Cancer Consortium.

The event is intended for researchers and healthcare professionals, and the cost for attendance is $40. For more information or to register call (808) 691-4406 or email at


Contact: Kevin Cassel
University of Hawaii Cancer Center

Related biology news :

1. Launch of BioLynx provides a boost for the international malaria research community
2. Fate of lakes focus of international meeting in Sunapee, N.H.
3. AACR hosts 10th International Conference on Frontiers in Cancer Prevention Research
4. Wiley-Blackwell signs three new international open access agreements
5. International study identifies new gene targets for hypertension treatment
6. Media invited: AVS 58th International Symposium and Exhibition
7. Mapping a model: International research on plant species appears in journal Nature
8. Systech International and Zetes Partner to Meet Europes Emerging Pharmaceutical Regulatory Requirements
9. Thermophile experts to hold international meeting Sept. 11-16 near Yellowstone National Park
10. International pharmacogenomics conference to focus on better drug treatment based on genetics
11. American Society of Human Genetics to host 12th International Congress of Human Genetics
Post Your Comments:
(Date:9/29/2015)... , Sept. 29, 2015 ... employee productivity while also saving energy , Minimized ... as Low Power Active Mode and embedded Fujitsu PalmSecure ... Fujitsu today shows that good things ... and refreshed models to its enterprise desktop and mobile ...
(Date:9/28/2015)... YORK , Sept. 28, 2015 /PRNewswire/ ... announced today that its expedited traveler service ... innovative platform transforms travel, bringing a frictionless ... its members. "CLEAR offers our ... enhances customer service," said Jim Smith ...
(Date:9/28/2015)... SAN FRANCISCO , September 28, 2015 ... size is expected to reach USD 12.03 billion by ... to 2020. Technological advancements such as Backside Illumination (BSI) ... revenue growth over the forecast period.      ... the back of the chip to reduce loss and, ...
Breaking Biology News(10 mins):
(Date:10/12/2015)... SAN FRANCISCO , October 12, 2015 ... reach USD 6.49 billion by 2022, according to a new ... can be attributed to rise in incidence of oncology diseases ... detection market is expected to reach USD 6.49 billion ... Research, Inc. This growth in demand can be attributed to ...
(Date:10/12/2015)... 12, 2015  Patara Pharma, a clinical-stage biotechnology ... diseases and conditions, today announced the closing of ... Concurrent with the close of its sale of ... and Security Agreement with Silicon Valley Bank whereby ... Patara will use the funds from the financing ...
(Date:10/12/2015)... Belgium , Oct. 12, 2015 VolitionRx ... from a completed clinical study of its NuQ ® ... in the online issue of Clinical Epigenetics , the ... was conducted in collaboration with Lund ... Roland Andersson , MD, PhD, Professor of Surgery and Vice-Dean, ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... LifeTrak ... the launch of LifeTrak Zoom, the world’s first amphibious fitness tracker that seeks to ... offers flexwear technology and accurate heart rate monitoring both in water and ...
Breaking Biology Technology: